Market revenue in 2023 | USD 647.5 million |
Market revenue in 2030 | USD 1,740.5 million |
Growth rate | 15.2% (CAGR from 2023 to 2030) |
Largest segment | Pure prp |
Fastest growing segment | Leukocyte Rich PRP |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pure PRP, Leukocyte Rich PRP |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Type | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
North America | 166.8 | 188.2 | 212.8 | 231.1 | 254.0 | 281.0 | 313.1 | 352.2 | 397.7 | 451.2 | 513.2 | 585.7 | 671.9 | 13.3% |
Europe | 84.4 | 97.3 | 112.6 | 125.1 | 140.7 | 159.3 | 181.6 | 209.2 | 241.9 | 281.1 | 327.5 | 383.1 | 450.4 | 16.0% |
Asia Pacific | 65.5 | 76.5 | 89.7 | 100.8 | 114.7 | 131.4 | 151.6 | 176.5 | 206.3 | 242.2 | 285.2 | 336.9 | 399.9 | 17.2% |
Latin America | 21.7 | 25.0 | 28.9 | 32.1 | 36.0 | 40.8 | 46.5 | 53.4 | 61.7 | 71.7 | 83.5 | 97.5 | 114.6 | 15.9% |
MEA | 17.8 | 20.8 | 24.2 | 27.1 | 30.7 | 35.0 | 40.2 | 46.6 | 54.3 | 63.5 | 74.5 | 87.6 | 103.7 | 16.8% |
Overall | 356.2 | 407.8 | 468.2 | 516.2 | 576.1 | 647.5 | 732.9 | 837.9 | 961.9 | 1,109.6 | 1,283.7 | 1,490.8 | 1,740.5 | 15.2% |
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account